Pnina Fishman - Can Fite CEO, Director
CANF Stock | 2.60 0.10 3.70% |
CEO
Dr. Pnina Fishman serves as Chief Executive Officer and served on our Board of Directors since September 2005. She has also served as the Chief Executive Officer of OphthaliX from November 21, 2011 through December 31, 2012. Dr. Fishman is the scientific founder of CanFite and was previously a professor of Life Sciences and headed the Laboratory of Clinical and Tumor Immunology at the Felsenstein Medical Research Institute, Rabin Medical Center, Israel. Dr. Fishman has authored or coauthored over 150 publications and presented the findings of her research at many major scientific meetings. Her past managerial experience included seven years as Chief Executive Officer of Mor Research Application, the technology transfer arm of Clalit Health Services, the largest healthcare provider in Israel. Mor Research Application was also the first clinical research organization in Israel. Dr. Fishman currently also serves as a member of the Board of Directors of F.D Consulting Ltd., Ultratrend Ltd., EyeFite Ltd. and OphthaliX Inc since 1994.
Age | 75 |
Tenure | 30 years |
Professional Marks | Ph.D |
Phone | (972) 3 9249378 |
Web | www.canfite.com |
Can Fite Management Efficiency
The company has return on total asset (ROA) of (0.5047) % which means that it has lost $0.5047 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of (1.345) %, meaning that it generated substantial loss on money invested by shareholders. Can Fite's management efficiency ratios could be used to measure how well Can Fite manages its routine affairs as well as how well it operates its assets and liabilities.Similar Executives
Found 1 records | CEO Age | ||
Anat CohenDayag | Compugen | 56 |
Management Performance
Return On Equity | -1.34 | |||
Return On Asset | -0.5 |
Can Fite Biopharma Leadership Team
Elected by the shareholders, the Can Fite's board of directors comprises two types of representatives: Can Fite inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Can. The board's role is to monitor Can Fite's management team and ensure that shareholders' interests are well served. Can Fite's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Can Fite's outside directors are responsible for providing unbiased perspectives on the board's policies.
Motti Farbstein, Chief Officer | ||
Abraham Sartani, Director | ||
Guy Regev, Director | ||
Sari Fishman, VP Devel | ||
Ilan Cohn, CoFounder Chairman | ||
FACP FACR, Clinical Advisor | ||
Ilan Cohen, Chairman of the Board | ||
Israel Shamay, External Director | ||
Pnina Fishman, CEO, Director |
Can Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Can Fite a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
Return On Equity | -1.34 | |||
Return On Asset | -0.5 | |||
Operating Margin | (13.51) % | |||
Current Valuation | 35.67 M | |||
Shares Outstanding | 1.01 B | |||
Price To Earning | (337.46) X | |||
Price To Book | 2.84 X | |||
Price To Sales | 85.87 X | |||
Revenue | 853 K | |||
Gross Profit | 853 K |
Pair Trading with Can Fite
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Can Fite position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Can Fite will appreciate offsetting losses from the drop in the long position's value.Moving together with Can Stock
0.62 | GPGB | GP Global Power | PairCorr |
Moving against Can Stock
0.51 | BOLT | BioLight Life Sciences | PairCorr |
The ability to find closely correlated positions to Can Fite could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Can Fite when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Can Fite - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Can Fite Biopharma to buy it.
The correlation of Can Fite is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Can Fite moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Can Fite Biopharma moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Can Fite can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Can Fite Biopharma. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in board of governors. You can also try the CEOs Directory module to screen CEOs from public companies around the world.
Complementary Tools for Can Stock analysis
When running Can Fite's price analysis, check to measure Can Fite's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Can Fite is operating at the current time. Most of Can Fite's value examination focuses on studying past and present price action to predict the probability of Can Fite's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Can Fite's price. Additionally, you may evaluate how the addition of Can Fite to your portfolios can decrease your overall portfolio volatility.
Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
Bonds Directory Find actively traded corporate debentures issued by US companies | |
Transaction History View history of all your transactions and understand their impact on performance | |
Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated | |
Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios | |
Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules | |
Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges |